plant lover, cookie monster, shoe fiend
17993 stories
·
21 followers

The Last Days of Mankind

1 Share

Today, the war on terror is widely accepted as a military and geopolitical failure. But it is still not fully understood as a massive intellectual and moral fiasco: an attempt by the Western media as well as the political class to forge reality itself, which failed catastrophically, but not without embedding cruelty and mendacity deep and enduringly in public life. And partly because this disaster was unacknowledged—editors and writers pushing false narratives, and cheerleading large-scale violence, remained entrenched, and even received promotions—it is being reenacted today in the Western media’s coverage of Israel’s war on Gaza: another war that has ignited a bonfire of international legal and moral norms and deadened and perverted consciences.
Read the whole story
sarcozona
4 hours ago
reply
Epiphyte City
Share this story
Delete

Global egg price surges as avian flu hits supplies

1 Share
Read the whole story
sarcozona
5 hours ago
reply
Epiphyte City
Share this story
Delete

Leila Al-Shami (@leilashami@spore.social)

1 Share
Read the whole story
sarcozona
8 hours ago
reply
Epiphyte City
Share this story
Delete

Joshua Idehen - Mum Does The Washing OFFICIAL VIDEO - YouTube

1 Share
Read the whole story
sarcozona
19 hours ago
reply
Epiphyte City
Share this story
Delete

NotebookLM

1 Share
Read the whole story
sarcozona
19 hours ago
reply
Epiphyte City
Share this story
Delete

FDA approves Bristol schizophrenia drug that could alter how disorder is treated

1 Comment

For decades, doctors caring for people with schizophrenia have relied on mood-regulating drugs that target the brain chemical dopamine. On Thursday, the Food and Drug Administration approved for the first time a new type of medicine that may change the way the psychiatric disorder is treated. 

The drug, called Cobenfy, will be sold by Bristol Myers Squibb. It was developed by the biotech company Karuna Therapeutics, which Bristol acquired for $14 billion last year

Cobenfy was approved to reduce the psychotic symptoms associated with schizophrenia. It is a new type of medicine that works by stimulating a pair of muscarinic receptors in the brain, that, in turn, control the release of a brain chemical called acetylcholine. 

STAT+

Already have an account? Log in

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe
Read the whole story
sarcozona
1 day ago
reply
So many drugs for disabling conditions are like this. You can be impoverished to treat your chronic illness or you can be impoverished because you’re too sick to work because of your untreated chronic illness or - my favourite - the drug works enough that you can kind of take care of yourself and your day-to-day life but you’re still not well enough to work and now you’re somehow even poorer.
Epiphyte City
Share this story
Delete
Next Page of Stories